NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuroVision Imaging

NeuroVision Imaging

Private
Sacramento, CaliforniaHealthcare & Life Scienceshttps://www.neurovision.com/

Last Round

Grant

Aug 24, 2021

Total Funding Raised

$27.74M

Company Overview

NeuroVision Imaging is a medical technology company that provides a telehealth platform and develops diagnostic tests and retinal imaging technology for the early detection and monitoring of Alzheimer's Disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Biotechnology, Telemedicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

neurodegenerative diagnosticsearly disease detectionAlzheimer's detectionretinal imagingblood biomarkerseye test for Alzheimer'sblood test for Alzheimer'stelehealth platformAI diagnosticsmulti-modal diagnosticstele-neurologymedical imaging AIcognitive carebrain healthprimary care diagnosticslongitudinal monitoringclinical trial support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroVision Imaging Comparables

Compare NeuroVision Imaging with similar companies based on industry and business-model similarity.

NeuroVision Imaging comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RetiSpec
81%
Cognoptix
78%
Head Diagnostics
77%

NeuroVision Imaging Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 24, 2021
GrantFeb 1, 2021
Series CMay 2, 2018
Series BJun 29, 2016

Key People

Founding team and executive leadership

Steven Verdooner

CEO

Executive Team

NeuroVision Imaging Investors

Notable investors and investment history

NeuroVision Imaging investors
InvestorRounds
Wildcat Capital ManagementSeries B, Series C
SBI Investment Co., Ltd.Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 56% month-over-month.

  • Nov 9, 2025

    Monthly visitors increased 178% MoM, reaching 4.1K.

NeuroVision Imaging Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuroVision Imaging Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroVision Imaging's valuation, stock price, and market status.

Firmographic Details

HeadquartersSacramento, California
Employee Range21
Year Founded2010
Last FundingAug 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.